Lv51
1260 积分 2022-08-30 加入
Measurement of Complement Hemolytic Activity, Generation of Complement-Depleted Sera, and Production of Hemolytic Intermediates
6天前
已完结
Simple quantitative haemolytic microassay for determination of complement alternative pathway activation (AP50)
6天前
已完结
Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
8天前
已完结
The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype
8天前
已完结
Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity
8天前
已完结
COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES
8天前
已完结
Naturally Occurring Anti-D in a Male Blood Donor, Unresolved Mystery
14天前
已完结
Drug Interaction Studies with Esomeprazole, the (S)-Isomer of Omeprazole
16天前
已关闭
Recommendations for Systematic Statistical Computation of Immunogenicity Cut Points
1个月前
已完结
Huperzine A, a novel promising acetylcholinesterase inhibitor
1个月前
已完结
皖公网安备34019202002308
